Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae472Source: DataRank Database

High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana is a research paper published in Journal of Antimicrobial Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)Impact (FWCI 1.22)OA: hybridTopics (88)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Goitseone Martha Lemogang,Wonderful T. Choga ORCID,Gaonyadiwe Muzanywa,Thembinkosi M Shadreck,Charity Ralegoreng

Live enrichment

PubMed:39764689 PMC:PMC11879200 OpenAlex:https://openalex.org/W4406198906

European Union

Grant: CSA2020NoE-3104

Bill & Melinda Gates Foundation

Grant: INV-033558

US National Institutes of Health

Grant: NIH K24 AI131928

FIC NIH HHS

Grant: D43 TW009610

FIC NIH HHS

Grant: K43 TW012350

NHGRI NIH HHS

Grant: U41 HG006941

NIAID NIH HHS

Grant: K24 AI131928

National Institutes of Health

Grant: 5K24AI131928-05

Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial

National Institutes of Health

Grant: 1K43TW012350-01

Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence

National Institutes of Health

Grant: 5D43TW009610-03

Fogarty HIV Research Training Program for Low and Middle-Income Countries

National Institutes of Health

Grant: 3U41HG006941-02S2

H3ABioNet: a sustainable African Bioinformatics Network for H3Africa

African Academy of Science

Human Health and Heredity in Africa Consortium

Trials of Excellence in Southern Africa

EDCTP2 program

African Academy of Sciences

H3ABioNet

Sub-Saharan African Network for TB/HIV Research Excellence

African Academy of Sciences

Human Health and Heredity in Africa Consortium

African Academy of Science

EDCTP2 program

H3ABioNet

Sub-Saharan African Network for TB/HIV Research Excellence

Trials of Excellence in Southern Africa

FWCI

1.22

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/jac/advance-article-pdf/doi/10.1093/jac/dkae472/61368286/dkae472.pdf

publisherhttps://academic.oup.com/jac/advance-article-pdf/doi/10.1093/jac/dkae472/61368286/dkae472.pdf

publisherhttps://academic.oup.com/jac/article-pdf/80/3/767/61368286/dkae472.pdf

journalhttps://doi.org/10.1093/jac/dkae472

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39764689

Fields of Study

HIV/AIDS drug development and treatmentHIV Research and TreatmentBiological Research and Disease Studies0303 health sciences03 medical and health sciencesHumansHeterocyclic Compounds, 3-RingPyridonesHIV InfectionsPiperazinesOxazinesDrug Resistance, ViralBotswanaMaleHIV-1FemaleAdultViral LoadMiddle AgedMutationReverse Transcriptase InhibitorsPrevalenceTriazinesAnti-HIV AgentsHIV Reverse TranscriptaseHIV Integrase InhibitorsAntiretroviral Therapy, Highly ActiveDolutegravir

MeSH Terms

DolutegravirAdultBotswanaFemaleHeterocyclic Compounds, 3-RingHumansMaleMiddle AgedMutationOxazinesPiperazinesPyridonesTriazinesHIV-1HIV InfectionsPrevalenceReverse Transcriptase InhibitorsAnti-HIV AgentsHIV Integrase InhibitorsViral LoadAntiretroviral Therapy, Highly ActiveDrug Resistance, ViralHIV Reverse TranscriptaseYoung Adult

Keywords

DolutegravirReverse transcriptaseAntiretroviral therapyHuman immunodeficiency virus (HIV)VirologyMedicineDrug resistanceResistance mutationHIV drug resistanceLentivirusReverse-transcriptase inhibitorBiologyViral loadViral diseasePolymerase chain reactionGeneticsMaleAdultBotswanaPyridonesTriazinesAnti-HIV AgentsHIV InfectionsMiddle AgedPiperazinesHIV Reverse TranscriptaseOxazinesDrug Resistance, ViralMutationHIV-1PrevalenceHumansReverse Transcriptase InhibitorsFemaleHeterocyclic Compounds, 3-RingOriginal Research

Sustainable Development Goals

SDG 0: Good health and well-being